Clinical Trials Browser

Suspended × OTHER × Neoplasm Metastasis × Clear all

NCT05204147 2026-04-22

Actinium 225 Labeled Anti-CEA Antibody (Ac225-DOTA-M5A) for the Treatment of CEA Producing Advanced or Metastatic Cancers

Phase 1 Suspended

Neoplasm Metastasis

NCT05091632 2026-04-15

Assessment of Verbal Comprehension and Cognitive Processes in Patients Admitted to the Palliative and Supportive Care Unit

Other hematologic neoplasm

Neoplasm Metastasis, Hematologic Neoplasms

NCT05351294 2026-01-07

Assessment of Early Radiation Oncology Involvement Alongside Standard Oncologic Care in the Managemet

Phase 3 Suspended

Neoplasm Metastasis

NCT05400122 2025-11-12

Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer

Phase 1 Suspended

GastrointestinalLymphoidMyeloidOther hematologic neoplasmPlasma cell

Esophageal Neoplasms, Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Neoplasm Metastasis, Rectal Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03610100 2019-10-29

ACELARATE

Phase 2/3 Suspended

Gastrointestinal

Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms